Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANAKINUMAB Cause Drug ineffective? 1,078 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,078 reports of Drug ineffective have been filed in association with CANAKINUMAB (Ilaris). This represents 10.3% of all adverse event reports for CANAKINUMAB.

1,078
Reports of Drug ineffective with CANAKINUMAB
10.3%
of all CANAKINUMAB reports
93
Deaths
400
Hospitalizations

How Dangerous Is Drug ineffective From CANAKINUMAB?

Of the 1,078 reports, 93 (8.6%) resulted in death, 400 (37.1%) required hospitalization, and 323 (30.0%) were considered life-threatening.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAKINUMAB. However, 1,078 reports have been filed with the FAERS database.

What Other Side Effects Does CANAKINUMAB Cause?

Pyrexia (1,327) Inappropriate schedule of drug administration (1,238) Inappropriate schedule of product administration (944) Pain (858) Condition aggravated (771) Malaise (684) Off label use (557) Arthralgia (555) Rash (505) Incorrect dose administered (497)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which CANAKINUMAB Alternatives Have Lower Drug ineffective Risk?

CANAKINUMAB vs CANDESARTAN CANAKINUMAB vs CANDESARTAN CILEXETIL CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE CANAKINUMAB vs CANGRELOR CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN

Related Pages

CANAKINUMAB Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective CANAKINUMAB Demographics